Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Bladder Cancer News Round-Up: The Latest in Bladder Cancer from Your JU Editor

April 25, 2024 | 7:30 p.m. ET

Join Editor-in-Chief of The Journal of Urology®, Dr. Robert Siemens, as he shares his perspectives on the latest news in bladder cancer. He’ll get you prepped and ready to join us in San Antonio with a one-on-one discussion on the latest research publishing in The Journal, his take on the hottest news from AUA, and what he’s most looking forward to about AUA2024 in San Antonio, TX. Come prepared for this interactive discussion with your questions for this global leader in all things bladder cancer.

Robert Siemens, MD, FRCSC

Robert Siemens, MD, FRCSC

Editor, The Journal of Urology®
Professor, Department of Urology, Queen’s University

Dr. Siemens is Professor and former Chair of the Department of Urology at Queen’s University and is Director of the Center for Applied Urological Research. Dr. Siemens is cross-appointed to the Departments of Oncology and Biomedical and Molecular Sciences and has published over 300 peer-reviewed original manuscripts and book chapters. His collaborative basic and translational science units have held continuous funding from granting agencies, including Prostate Cancer Canada, USDOD CDMRP, NSERC, and CIHR. Dr. Siemens’ interests have focused on the effects of micro-environmental changes on cancer behavior and particularly the ability of cancer cells to evade immune detection. He has built strong collaborations with other principal investigators in the Departments of Biomedical and Molecular Sciences, Pathology and Molecular Medicine and School of Computing. Dr. Siemens has also formed a research network including epidemiologists, radiation and medical oncologists, nursing and cognitive psychologists focused on numerous prostate and bladder cancer survivorship issues, including patient information and decision aids, as well as indicators of quality of surgical care. He is Editor-in-Chief of The Journal of Urology® and is the President of the Canadian Urological Association.